Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03694145 · ClinicalTrials.gov registry record
Predicting Diabetic Retinopathy From Risk Factor Data and Digital Retinal Images
A clinical trial of Diabetic Macular Edema and Diabetic Retinopathy, sponsored by Charles Drew University of Medicine and Science.
- Active
- Registry status
- 300
- Enrollment target
- 3
- Study locations
NCT03694145: Active study of Diabetic Macular Edema and Diabetic Retinopathy, sponsored by Charles Drew University of Medicine and Science.
NCT03694145 is a study of Diabetic Macular Edema and Diabetic Retinopathy that is active but no longer recruiting, run by Charles Drew University of Medicine and Science. The registered enrollment target is 300 participants, below the 3,790-participant average among 63 other Diabetic Macular Edema trials with a reported enrollment target (92% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03694145, a study of Diabetic Macular Edema and Diabetic Retinopathy, is active but no longer recruiting, sponsored by Charles Drew University of Medicine and Science.
- ACTIVE NOT RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 3
- Study locations
Study Summary
The objective of this study is to compare the results of a deep learning approach to diabetic retinopathy assessment with results from (1) an in-person examination with an ophthalmologist, and (2) the assessments of optometrists involved in a teleretinal screening program.
Primary Outcome
Proportion of patients accurately diagnosed with retinopathy using machine learning versus proportion accurately diagnosed by teleretinal screening optometrists with in-person eye examinations by ophthalmologists used as a gold standard.
Conditions Studied
Interventions
- OTHER In-Person Eye Examination
Study Locations (3)
California
- Los Angeles Department of Public Health - Los Angeles
- University of California - Los Angeles - Los Angeles
- Charles R. Drew University of Medicine and Science - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2018-10-25 |
| Est. Completion | 2025-07-31 |
What the registry record for NCT03694145 still lists
NCT03694145 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 3,790-participant average among 63 other Diabetic Macular Edema trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Diabetic Macular Edema appearing as the primary indexed condition, and to 1 intervention - of which In-Person Eye Examination is the first listed.
NCT03694145 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03694145 about?
NCT03694145 is a clinical study titled "Predicting Diabetic Retinopathy From Risk Factor Data and Digital Retinal Images". The objective of this study is to compare the results of a deep learning approach to diabetic retinopathy assessment with results from (1) an in-person examination with an ophthalmologist, and (2) the assessments of optometrists involved in a teleretinal screening program.
What is the current status of trial NCT03694145?
This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2018-10-25. Estimated completion is 2025-07-31.
What conditions does trial NCT03694145 study?
This clinical trial studies the following conditions: Diabetic Macular Edema, Diabetic Retinopathy.
What interventions are being tested in trial NCT03694145?
The interventions under investigation include: In-Person Eye Examination (OTHER).
Who is sponsoring clinical trial NCT03694145?
This trial is sponsored by Charles Drew University of Medicine and Science, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03694145 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Macular Edema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03694145's enrollment target sits among peer trials
300 14th of 63 higher than 49 of 63 other Diabetic Macular Edema trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Macular Edema trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of K9 in Subjects With Diabetic Macular Edema (DME)
RECRUITING · Phase 1
-
EC-104 Intravitreal Implant for the Treatment of Diabetic Macular Edema
RECRUITING · Phase 1
-
Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
RECRUITING · Phase 1
-
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
RECRUITING · Phase 3
-
A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME
RECRUITING · Phase 3
-
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI